An Open Label Prostate Cancer Study in Japanese Patients

Exclusion Criteria

• •History of hypersensitivity to active or inactive excipients of AZD3514 or drugs with a similar chemical structure or class to AZD3514
• •Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the formulated product or previous significant bowel resection that would preclude adequate absorption of AZD3514
• •Inadequate bone marrow reserve or organ function
• •Concurrent or recent treatment with certain medications or medical procedures
• •Any medically important factors identified from electrocardiogram (ECG) measurements